Related Experiment Videos
Differential modulation of cyclin gene expression by MYC
P Jansen-Dürr1, A Meichle, P Steiner
1Forschungsschwerpunkt Angewandte Tumorvirologie, Deutsches Krebsforschüngs Zentrüm, Heidelberg, Federal Republic of Germany.
Summary
The human c-MYC protooncogene regulates cell cycle progression by modulating cyclin A, E, and D1 expression. MYC activation increases cyclin A and E, promoting cell cycle entry, while decreasing cyclin D1, inhibiting G1 phase progression.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Oncogenesis
Background:
- The c-MYC protooncogene is a transcription factor crucial for cell growth and proliferation.
- Deregulated MYC expression is implicated in various cancers.
- Understanding MYC's role in cell cycle control is vital for cancer research.
Purpose of the Study:
- To investigate the impact of deregulated human c-MYC expression on cyclin gene expression.
- To examine the effect of MYC on the transcription factor E2F.
- To elucidate the mechanisms by which MYC influences cell cycle progression.
Main Methods:
- Constitutive expression of MYC and activation of conditional MycER chimeras.
- Analysis of cyclin A, E, and D1 mRNA levels.
- Assessment of cyclin A-cdk2 association with E2F.
- Measurement of E2F transcriptional activity.
Main Results:
- Constitutive MYC expression elevated cyclin A and cyclin E mRNA levels.
- MYC-activated cyclin A expression induced growth factor-independent cyclin A-cdk2-E2F complex formation.
- E2F transcriptional activity increased following MYC activation.
- Cyclin D1 expression was significantly reduced in MYC-transformed cells, occurring early in G1 phase.
Conclusions:
- Deregulation of c-MYC profoundly impacts cell cycle machinery.
- MYC promotes cell cycle progression by upregulating cyclins A and E and enhancing E2F activity.
- MYC actively represses cyclin D1, indicating a complex role in G1 phase regulation.